Glycan macro-and microheterogeneity have profound impacts on protein folding and function. This heterogeneity can be regulated by physiological or environmental factors. However, unregulated heterogeneity can lead to disease, and mutations in the glycosylation process cause a growing number of Congenital Disorders of Glycosylation. We systematically studied how mutations in the N-glycosylation pathway lead to defects in mature proteins using all viable Saccharomyces cerevisiae strains with deletions in genes encoding Endoplasmic Reticulum lumenal mannosyltransferases (Alg3, Alg9, and Alg12), glucosyltransferases (Alg6, Alg8, and Die2/Alg10), or oligosaccharyltransferase subunits (Ost3, Ost5, and Ost6). To measure the changes in glycan macro-and microheterogeneity in mature proteins caused by these mutations we developed a SWATH-mass spectrometry glycoproteomics workflow. We measured glycan structures and occupancy on mature cell wall glycoproteins, and relative protein abundance, in the different mutants. All mutants showed decreased glycan occupancy and altered cell wall proteomes compared with wild-type cells. Mutations in earlier mannosyltransferase or glucosyltransferase steps of glycan biosynthesis had stronger hypoglycosylation phenotypes, but glucosyltransferase defects were more severe. ER mannosyltransferase mutants displayed substantial global changes in glycan microheterogeneity consistent with truncations in the glycan transferred to protein in these strains. Although ER glucosyltransferase and oligosaccharyltransferase subunit mutants broadly showed no change in glycan structures, ost3⌬ cells had shorter glycan structures at some sites, consistent with increased protein quality control mannosidase processing in this severely hypoglycosylating mutant. This method allows facile relative quantitative glycoproteomics, and our results provide insights into global regulation of site-specific glycosylation. Protein glycosylation is a highly conserved co-and posttranslocational modification of proteins that influences protein folding, stability, solubility, and function (1, 2). N-glycosylation of Asparagine (Asn) 1 residues occurs in eukaryota, archaea, and some bacteria, although the biosynthetic pathways and glycan structures are diverse in these organisms (3). In eukaryotes, nascent polypeptides in the Endoplasmic Reticulum (ER) are the protein acceptor substrates for N-glycosylation, as folded proteins cannot be efficiently N-glycosylated and N-glycosylation is critical for efficient protein folding. After protein folding, glycan structures can be further truncated or extended by Golgi-resident glycosyltransferases. Glycan biosynthesis is inherently inefficient, resulting in structural diversity of mature glycoproteins. Diversity in the presence or absence of glycans on glycoproteins is termed macroheterogeneity, whereas diversity in the structures of glycans at a specific site is termed microheterogeneity. This structural diversity is key for the regulation of many biological functions of glycoproteins...